Chanroeurn Hak

Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis

F.–X. Blanc, Sok Thim, Didier Laureillard et al. · New England Journal of Medicine · 2011 · 615 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17

Causes and Determinants of Mortality in HIV-Infected Adults With Tuberculosis: An Analysis From the CAMELIA ANRS 1295-CIPRA KH001 Randomized Trial

Olivier Marcy, Didier Laureillard, Yoann Madec et al. · Clinical Infectious Diseases · 2014 · 45 citations · Full text

Public Health, Health Sciences, Infectious Diseases +17

High efficacy of lopinavir/r‐based second‐line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

Laurent Ferradini, Vara Ouk, Olivier Ségéral et al. · Journal of the International AIDS Society · 2011 · 43 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial

F.–X. Blanc, Sok Thim, Didier Laureillard et al. · BMC Proceedings · 2011 · 37 citations · Full text

Public Health, Immunology, Infectious Diseases +12

Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia

Setha Limsreng, Olivier Marcy, Sowath Ly et al. · PLoS ONE · 2016 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17